Facts from the filing
Form 4 · Derivative, table II- Disclosed value
- $0Shares × reported price
- Shares traded
- 11,236,631Pre-Funded Warrant (right to buy)
- Price per share
- $0.00Reported price. Read footnotes for ranges.
- % of reported position traded
- UnavailableThis security and ownership context
- Holdings after
- 0Indirect · By Daewoong Pharmaceutical Co., Ltd.
- Trade date
- Oct 30, 2026Derivative exercise
- Filed
- Nov 10, 2026, 11:35 AM ET11-day reporting delay
- Accession
- 0001213900-26-117865Code X · Transaction 396741
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.